# AccuRna

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/accurna

- Industry: Pharmaceuticals
- Headquarters: Tokyo, Japan
- Website: www.accurna.com/
- Total disclosed funding: $4.7M
- Latest round: Series B (Dec 23, 2019)
- Investors on record: 4

## About

Founded in 2015 and based in Tokyo, Japan, AccuRna, Inc. is a solution provider in the area of nucleic acid therapeutics. The Company develops the drug delivery system (DDS) for nucleic acid therapeutics, both of short chain including ASO, siRNA, miRNA and long chain, mRNA as a therapeutic drug, providing treatment for refractory diseases.

## Funding rounds

- Series B, Dec 23, 2019 — Fast Track Initiative, UTokyo Innovation Platform
- Series B, Jan 17, 2018, $4.7M — SMBC Venture Capital, Fast Track Initiative, UTokyo Innovation Platform, NanoCarrier Co., Ltd.
- Series A, Mar 17, 2016 — Fast Track Initiative, NanoCarrier Co., Ltd.

## Investors

- Fast Track Initiative (https://capitalatlas.ai/funds/fast-track-initiative) — Series A, Series B
- NanoCarrier Co., Ltd. — Series A, Series B
- SMBC Venture Capital (https://capitalatlas.ai/funds/smbc-venture-capital) — Series B
- UTokyo Innovation Platform (https://capitalatlas.ai/funds/utokyo-innovation-platform) — Series B